Four-year follow up data for Roche's Evrysdi show continued increase in number of children with a severe form of spinal muscular atrophy (SMA) able to sit, stand and walk Seite 1

30.06.2023 - Data from ongoing FIREFISH study confirm long-term efficacy and safety profile of Evrysdi in children with Type 1 SMANinety-one percent of children were alive at month 48More than 95% maintained the ability to swallow - without treatment they would ... Seite 1

Related Keywords

London ,City Of ,United Kingdom ,Giovanni Baranello ,Toddler Development Third Edition ,Institute Of Child Health Hospital ,Research Clinical Care Meeting ,Gross Motor Scale ,Bayley Scales ,Hammersmith Infant Neurological Examination ,Clinical Care Meeting ,Ormond Street Institute ,Child Health ,Great Ormond Street Hospital ,Roche Holding ,